ArticleBMC cancer2022

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis.

Jin Suminokura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.